(Q35978279)

11 August 2017

rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU. (English)

1 reference

11 August 2017

Rampling R

1

1 reference

11 August 2017

Steward W

2

1 reference

11 August 2017

Paul J

3

1 reference

11 August 2017

Macham MA

4

1 reference

11 August 2017

Harvey E

5

1 reference

11 August 2017

Eckley D

6

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 1994

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

69

1 reference

11 August 2017

3

1 reference

11 August 2017

541-545

1 reference

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

Recombinant human granulocyte macrophage colony-stimulating factor: current status of clinical trials and potential future applications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

Phase II study of tauromustine in malignant glioma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (2).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor (1).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

High-dose BCNU with autologous bone marrow rescue for recurrent glioblastoma multiforme.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

Cell kinetic analysis of human brain tumors byin situ double labelling with bromodeoxyuridine and iododeoxyuridine

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1968853

Chemotherapy for malignant gliomas

24 September 2018

1 reference

12 December 2020

Effect of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor on Hematopoietic Reconstitution after High-Dose Chemotherapy and Autologous Bone Marrow Transplantation

1 reference

12 December 2020

Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression

1 reference

12 December 2020

Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1994.98

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

8123485

1 reference